News Medical on MSN2d
FXR cyclic peptide antagonists as a novel strategy for MASH treatmentIn this study, the authors first used an AlphaScreen assay to identify a series of tryptophan-based cyclic peptide compounds with FXR-antagonistic activity, specifically those modified with a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback